Your browser doesn't support javascript.
loading
Discovery of novel TLR4/MD-2 inhibitors: Receptor structure-based virtual screening studies and anti-inflammatory evaluation.
Zhang, Tengyue; Xing, Siqi; Du, Jiyu; Xia, Jucheng; Dong, Shuanghong; Li, Zeng; Liu, Zhicheng; Song, Yang.
  • Zhang T; Department of Oncology, Anhui Provincial Cancer Hospital, West Branch of the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui In
  • Xing S; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230000, China; The Affiliated Suqian First People's Hospital of Nanjing Medical University, SuQian 223800, China.
  • Du J; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230000, China.
  • Xia J; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230000, China.
  • Dong S; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230000, China.
  • Li Z; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230000, China. Electronic address: lizeng@ahmu.edu.cn.
  • Liu Z; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230000, China. Electronic address: liuzhicheng@ahmu.edu.cn.
  • Song Y; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230000, China; Department of Pain, The First Affiliated Hospital of Anhui Medical University, Anhui Medical Uiversity, Hefei 230032, China.
Bioorg Chem ; 141: 106880, 2023 12.
Article en En | MEDLINE | ID: mdl-37783098
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antígeno 96 de los Linfocitos / Receptor Toll-Like 4 / Antiinflamatorios Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Animals Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antígeno 96 de los Linfocitos / Receptor Toll-Like 4 / Antiinflamatorios Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Animals Idioma: En Año: 2023 Tipo del documento: Article